2007
DOI: 10.1373/clinchem.2007.088005
|View full text |Cite
|
Sign up to set email alerts
|

Chip-Based Genotyping: Translation of Pharmacogenetic Research to Clinical Practice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…Before individual genome sequencing becomes routine, DNA (or gene) chips can be considered as one of the critical pharmacogenetics technologies. Featuring a tiny DNA microarray, gene chips reveal the level of activation of particular genes and assess a patient’s genetic suitability for certain drugs [ 105 ]. Technological advancements in sequencing have facilitated the integration of pharmacogenetics (or pharmacogenomics) in clinical diagnostics, allowing doctors to prescribe medication based mainly on their individual patient’s genetics rather than factors like age and body mass [ 106 ].…”
Section: How Has the Cracking Of Genetic Code Improved Life On Earth?mentioning
confidence: 99%
“…Before individual genome sequencing becomes routine, DNA (or gene) chips can be considered as one of the critical pharmacogenetics technologies. Featuring a tiny DNA microarray, gene chips reveal the level of activation of particular genes and assess a patient’s genetic suitability for certain drugs [ 105 ]. Technological advancements in sequencing have facilitated the integration of pharmacogenetics (or pharmacogenomics) in clinical diagnostics, allowing doctors to prescribe medication based mainly on their individual patient’s genetics rather than factors like age and body mass [ 106 ].…”
Section: How Has the Cracking Of Genetic Code Improved Life On Earth?mentioning
confidence: 99%